These results demonstrated that YB-1 promoted the growth of the xenografted human lung adenocarcinoma through the MACC1 pathway in vivo and suggested that YB-1 could be a therapeutic target for lung adenocarcinoma. The gene discussed is MACC1; the disease is lung adenocarcinoma.